A couple of well connected and well qualified venture capitalists approach us proposing a well rehearsed business plan and opportunity to partner with them at little to no risk. We don’t have to sell out, we’re branching out This adds real value to the company I believe. Have Rob and Cheryl penned a good enough deal for our part in the venture? What scope is there to manoeuvre a better deal for shareholders as the partnership develops? Looking forward to hearing the finer details today.
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-62
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.20M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.8¢ | $67.06K | 673.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 150305 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 21082 | 2 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.5¢ | 9.8¢ | 355338 | ||
| Last updated 14.59pm 07/06/2024 ? | |||||
| SPL (ASX) Chart |